By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bio-Rad reported after the close of the market Tuesday that its second-quarter revenues increased around 9 percent, with double-digit growth for its clinical diagnostics business offsetting slow growth for its life science segment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.